Successes and challenges in modeling heterogeneous BRAFV600E mutated central nervous system neoplasms [PDF]
Frontiers in Oncology, 2023 Central nervous system (CNS) neoplasms are difficult to treat due to their sensitive location. Over the past two decades, the availability of patient tumor materials facilitated large scale genomic and epigenomic profiling studies, which have resulted in
Yao Lulu Xing +2 more
doaj +2 more sources
Immunohistochemical Study of Ki-67 Labelling Index in Neoplasms of Central Nervous System [PDF]
National Journal of Laboratory Medicine, 2022 Introduction: The central nervous system tumours show a varied histopathological spectrum. The cell proliferation index may provide an objective method for assessing tumour biology. The Ki-67 is considered to be the most reliable proliferative marker
Anuradha G Patil +3 more
doaj +3 more sources
The Continuing Value of Ultrastructural Observation in Central Nervous System Neoplasms in Children [PDF]
Journal of Pathology and Translational Medicine, 2015 Central nervous system (CNS) neoplasms are the second most common childhood malignancy after leukemia and the most common solid organ neoplasm in children. Diagnostic dilemmas with small specimens from CNS neoplasms are often the result of multifactorial
Na Rae Kim, Sung-Hye Park
doaj +2 more sources
THE MAIN DIRECTIONS FOR PHARMACOLOGICAL CORRECTION (COMBINATIONS OF DRUGS FOR GENERAL ANESTHESIA) OF NEUROLOGICAL AND COGNITIVE DISORDERS IN PATIENTS WITH NEOPLASMS OF THE CENTRAL NERVOUS SYSTEM [PDF]
Research Results in Pharmacology, 2017 Introduction: the problem of neuroprotective or neurodegenerative effects of drugs for general anesthesia is relevant in connection with a large number of cases of postoperative cognitive dysfunction (POCD).
Andrey Kolesnikov +5 more
doaj +7 more sources
Intraoperative Frozen Cytology of Central Nervous System Neoplasms: An Ancillary Tool for Frozen Diagnosis [PDF]
Journal of Pathology and Translational Medicine, 2019 Background Pathologic diagnosis of central nervous system (CNS) neoplasms is made by comparing light microscopic, immunohistochemical, and molecular cytogenetic findings with clinicoradiologic observations.
Myunghee Kang +18 more
doaj +2 more sources
Histopathological Study of Central Nervous System Lesions: Emphasizing Association of Neoplasms with ABO Blood Groups [PDF]
Journal of Clinical and Diagnostic Research, 2017 Introduction: The Central Nervous System (CNS) lesions show considerable geographic and racial variations with respect to the incidence and the pattern of distribution of lesions.
B.N. KUMARGURU +5 more
doaj +3 more sources
Characterization of the blood brain barrier in pediatric central nervous system neoplasms. [PDF]
J Interdiscip Histopathol, 2016 Hong CS +5 more
europepmc +3 more sources
Brazilian Dental Science, 2016 Objective: The aim of this study was to evaluate the frequency of tooth abnormalities in pediatric patients treated for central nervous system neoplasms. Material and methods: This cross-sectional study assessed thirty-one patients, median age 14.2 years
Ornella Florio Demasi +4 more
doaj +3 more sources
Frequency of BRAF V600E mutations in 969 central nervous system neoplasms. [PDF]
Diagn Pathol, 2016 Behling F +10 more
europepmc +3 more sources
INSM1 Expression Is Frequent in Primary Central Nervous System Neoplasms but Not in the Adult Brain Parenchyma. [PDF]
J Neuropathol Exp Neurol, 2018 Ames HM +4 more
europepmc +3 more sources